Blueprint Medicines
BPMC
#2524
Rank
HK$45.26 B
Marketcap
HK$714.65
Share price
0.81%
Change (1 day)
80.69%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -HK$71.97

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -HK$71.64. In 2022 the company made an earnings per share (EPS) of -HK$72.88 an increase over its 2021 EPS that were of -HK$85.59.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$71.97-1.25%
2022-HK$72.88-14.85%
2021-HK$85.59-297.13%
2020HK$43.42-176.3%
2019-HK$56.9035.19%
2018-HK$42.0938.82%
2017-HK$30.3247.35%
2016-HK$20.589.25%
2015-HK$18.84-31.35%
2014-HK$27.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$0.55-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.90-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA